Methods for labeling beta-amyloid plaques and neurofibrillary tangles
    1.
    发明申请
    Methods for labeling beta-amyloid plaques and neurofibrillary tangles 有权
    β-淀粉样蛋白斑和神经原纤维缠结的标记方法

    公开(公告)号:US20020022002A1

    公开(公告)日:2002-02-21

    申请号:US09891883

    申请日:2001-06-26

    摘要: A method for labeling null-amyloid plaques and neurofibrillary tangles in vivo and in vitro, comprises contacting a compound of formula (I): 1 with mammalian tissue. In formula (I), R1 is selected from the group consisting of nullC(O)-alkyl, nullC(O)-alkylenyl-R4, nullC(O)O-alkyl, nullC(O)O-alkylenyl-R4, nullCnullC(CN)2-alkyl, nullCnullC(CN)2-alkylenyl-R4, 2 R4 is a radical selected from the group consisting of alkyl, substituted alkyl, aryl and substituted aryl; R5 is a radical selected from the group consisting of nullNH2, nullOH, nullSH, nullNH-alkyl, nullNHR4, nullNH-alkylenyl-R4, nullO-alkyl, nullO-alkylenyl-R4, nullS-alkyl, and nullS-alkylenyl-R4; R6is a radical selected from the group consisting of nullCN, nullCOOH, nullC(O)O-alkyl, nullC(O)O-alkylenyl-R4, nullC(O)-alkyl, nullC(O)-alkylenyl-R4, nullC(O)-halogen, nullC(O)NH2, nullC(O)NH-alkyl, nullC(O)NH-alkylenyl-R4; R7 is a radical selected from the group consisting of O, NH, and S; and R8 is N, O or S. R2 and R3 are each independently selected from the group consisting of alkyl and alkylenyl-R10, wherein R10 is selected from the group consisting of nullOH, nullOTs, halogen, spiperone, spiperone ketal and spiperone-3-yl. Alternatively, R2 and R3 together form a heterocyclic ring, optionally substituted with at least one radical selected from the group consisting of alkyl, alkoxy, OH, OTs, halogen, alkylenyl-R10, carbonyl, spiperone, spiperone ketal and spiperone-3-yl. In the compounds of formula (I), one or more of the hydrogen, halogen or carbon atoms can, optionally, be replaced with a radiolabel.

    摘要翻译: 一种用于在体内和体外标记β-淀粉样蛋白斑和神经原纤维缠结的方法,包括使式(I)化合物与哺乳动物组织接触。 在式(I)中,R 1选自-C(O) - 烷基,-C(O) - 亚烷基基-R 4,-C(O)O-烷基,-C(O)O-亚烷基 - R4,-C = C(CN)2-烷基,-C = C(CN)2 - 亚烷基-R4,R4为选自烷基,取代烷基,芳基和取代芳基的基团; R5是选自-NH2,-OH,-SH,-NH-烷基,-NHR4,-NH-亚烷基-R4,-O-烷基,-O-亚烷基-R4,-S-烷基的基团 和-S-亚烷基基-R4; R6是选自-CN,-COOH,-C(O)O-烷基,-C(O)O-亚烷基基-R4,-C(O) - 烷基,-C(O) - 亚烷基 -R 4,-C(O) - 卤素,-C(O)NH 2,-C(O)NH-烷基,-C(O)NH-亚烷基基-R4; R7是选自O,NH和S的基团; 并且R 8是N,O或S.R 2和R 3各自独立地选自烷基和亚烷基-R 10,其中R 10选自-OH,-OT,卤素,螺哌
    酮,螺哌酮缩酮和螺哌隆 -3-基。 或者,R2和R3一起形成杂环,任选被至少一个选自烷基,烷氧基,OH,OT,卤素,亚烷基-R 10,羰基,螺哌
    酮,螺哌酮缩酮和螺哌酮-3-基 。 在式(I)的化合物中,氢,卤素或碳原子中的一个或多个可以任选地被放射性标记代替。